Ann: US FDA 510k Submitted for APAS Independence, page-31

Hi Bonneylad,

Good summary of some of managements failures for the past two years, but you seem to have missed one very important point.

Credit raises are performed because the public companies are not making enough money to keep the doors open. Without the promised sales LBT will run out of money and I think they were claiming to be cash positive in 2020. How long until they start backing away from that statement in a company announcement. We were promised at least one sale in 2017 and here we are in 2019 still with only one sale and I believe the current company statement is to expect "modest sales" for 2019. The reality of these failed credit raises are that the company has missed out on receiving millions of dollars in lapsed options and most of the investors in the past 2.5 years have lost money. The share price is a reflection that the market has no faith in the company meeting any of their milestones for the past two years. I wish your belief that no one would give them any more money was correct but I believe it is now only a matter of time until the next credit raising because they cannot sell any machines.